- Home
- YMAB vs EMX Comparison
YMAB vs EMX Comparison
Compare YMAB & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- EMX
- Stock Information
- Founded
- YMAB 2015
- EMX N/A
- Country
- YMAB United States
- EMX Canada
- Employees
- YMAB N/A
- EMX N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- EMX
- Sector
- YMAB Health Care
- EMX
- Exchange
- YMAB Nasdaq
- EMX Nasdaq
- Market Cap
- YMAB 192.4M
- EMX 219.2M
- IPO Year
- YMAB 2018
- EMX N/A
- Fundamental
- Price
- YMAB $4.60
- EMX $2.34
- Analyst Decision
- YMAB Buy
- EMX Strong Buy
- Analyst Count
- YMAB 11
- EMX 1
- Target Price
- YMAB $17.55
- EMX $5.00
- AVG Volume (30 Days)
- YMAB 226.0K
- EMX 431.6K
- Earning Date
- YMAB 05-13-2025
- EMX 05-12-2025
- Dividend Yield
- YMAB N/A
- EMX N/A
- EPS Growth
- YMAB N/A
- EMX N/A
- EPS
- YMAB N/A
- EMX 0.00
- Revenue
- YMAB $88,658,000.00
- EMX $29,630,000.00
- Revenue This Year
- YMAB N/A
- EMX N/A
- Revenue Next Year
- YMAB $16.03
- EMX $12.71
- P/E Ratio
- YMAB N/A
- EMX $1,274.26
- Revenue Growth
- YMAB 4.92
- EMX N/A
- 52 Week Low
- YMAB $3.55
- EMX $1.59
- 52 Week High
- YMAB $16.11
- EMX $2.45
- Technical
- Relative Strength Index (RSI)
- YMAB 56.43
- EMX 61.28
- Support Level
- YMAB $3.99
- EMX $2.17
- Resistance Level
- YMAB $5.00
- EMX $2.45
- Average True Range (ATR)
- YMAB 0.35
- EMX 0.08
- MACD
- YMAB 0.10
- EMX 0.02
- Stochastic Oscillator
- YMAB 70.47
- EMX 75.56
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.